Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index; 10 of the 13 sources its claims cite were checked for support.

Suspected cholinergic toxicity due to cevimeline hydrochloride and Bacopa monnieri interaction: a case report

Open access
Acquarulo, Blake, Tandon, Priya, Macica, Carolyn M. · 2022 · Journal of Medical Case Reports

Abstract

Background: Muscarinic agonists are indicated for the treatment of many conditions including ileus, urinary retention, glaucoma, and Sjögren’s syndrome. Due to their lack of tissue specificity, these drugs can lead to undesirable side effects at off-target sites and may be potentiated by supplements that impact the half-life of these drugs. Case presentation: A 58-year-old Caucasian female with history of Sjögren’s syndrome, who was being managed with cevimeline, presented to the primary care office with reported hyperhidrosis, malaise, nausea, and tachycardia. She reported taking an herbal supplement containing B. monnieri and phosphatidylserine the previous night. It has been previously demonstrated that B. monnieri alters cytochrome P450 enzymes. Electrocardiogram showed no acute ST–T changes. Clinical improvement occurred with hydration and discontinuation of the supplement. Conclusions: To our knowledge, there has only been one other documented cevimeline overdose, and it was not associated with an herbal supplementation interaction. Physicians should actively elicit herbal supplement information from patients to anticipate possible drug–herb interactions. An additional consideration of clinical relevance is the known genetic variability that may affect drug responsiveness due to differences in metabolism and half-life of drugs that arise from common genetic variants of cytochrome P450 genes.

Overview

CoChat Summary

TL;DR

A 58-year-old woman with Sjögren’s syndrome on cevimeline developed acute tachycardia, hyperhidrosis, malaise, nausea, and tenesmus within 30 minutes of taking a Bacopa monnieri/phosphatidylserine supplement; symptoms resolved with hydration and supplement discontinuation. The authors hypothesize a drug–herb interaction via B. monnieri inhibition of CYP3A4/CYP2D6, which metabolize cevimeline, causing suspected cholinergic toxicity.

Key findings

  • The patient was a 58-year-old Caucasian female with Sjögren’s syndrome and subacute cutaneous lupus erythematosus, prescribed cevimeline 30 mg three times daily and hydroxychloroquine 150 mg daily.
  • After taking her usual 30 mg cevimeline plus two gummy tablets of a B. monnieri- and phosphatidylserine-containing supplement, she reported acute onset within 30 minutes of tachycardia, hyperhidrosis, malaise, nausea, and tenesmus.
  • Physical exam showed blood pressure 127/77, pulse oximetry 94% on room air, and ECG with no acute ST–T changes and normal heart rate of 83; symptoms subsided after hydration and supplement discontinuation.
  • The authors note B. monnieri acts as a competitive inhibitor of CYP3A4 and a weak inhibitor of CYP2D6 in vitro, while cevimeline is metabolized primarily by CYP2D6, CYP3A3, and CYP3A4, supporting a hypothesized interaction.

Methods

  • Single case report of one patient presenting to primary care with suspected cholinergic toxicity after cevimeline and an herbal supplement.
  • Data included clinical history, physical examination, ECG, and telephone follow-up; no laboratory drug levels or genetic testing were reported.
  • Main analysis is descriptive and hypothesis-generating, linking the patient’s symptoms to possible CYP-mediated elevation of cevimeline due to B. monnieri.

Limitations

  • The paper states there was a lack of detailed information on the supplement’s composition and that a definitive causal link between symptom onset and the B. monnieri-containing supplement cannot be established.
  • The paper also notes the patient’s CYP metabolic profile was unknown and not standard.
  • Evident from the text: this is a single case with no measured cevimeline concentrations, no CYP genotype, and no rechallenge, so the proposed drug–herb interaction remains suspected rather than confirmed.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s13256-022-03479-4

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

8 Valid · 1 Not valid · 3 Not checked · 13 Own results and interpretations

3 more claims

Create a free account to see all 25 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 13
  • Probably not a substantial claim. 9
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Citations

Cites

Show all 15 references

Research works printed but not linked: 1

  1. Patel R, Shahane A. The epidemiology of Sjogren’s syndrome. Clin Epidemiol. 2014;6:247–55.

Cited by

See all 8

Metadata

Authors
Acquarulo, B., Tandon, P., & Macica, C. M.
Affiliations
Quinnipiac University (US)
Corresponding author
Macica, Carolyn M.
Venue
Journal of Medical Case Reports
Published
2022-06-29
Volume
16
Issue
1
Pages
253-253
ISSN
1752-1947 (ISSN-L)
OpenAlex
W4283705211
Cited by
8
References
15
Citations by year
2026: 1 · 2025: 4 · 2024: 2 · 2023: 1
FWCI
1.73
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Medical Case Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
Keywords
cholinergic toxicity, cevimeline, Bacopa monnieri, herb-drug interactions, Sjögren's syndrome, herbal supplements, phosphatidylserine, muscarinic agonists, hyperhidrosis, tachycardia, cytochrome P450, drug overdose
MeSH terms
Cytochrome P-450 Enzyme System, Female, Humans, Middle Aged, Quinuclidines, Sjogren's Syndrome, Thiophenes, Cholinergic Agents, Bacopa

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Suspected cholinergic toxicity due to cevimeline hydrochloride and Bacopa monnieri interaction: a case report. https://app.cochat.ai/papers/10.1186/s13256-022-03479-4
The paper
Acquarulo, B., Tandon, P., & Macica, C. M. (2022). Suspected cholinergic toxicity due to cevimeline hydrochloride and Bacopa monnieri interaction: a case report. Journal of Medical Case Reports. https://doi.org/10.1186/s13256-022-03479-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.